do not crush, chew, or break extended-release tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours (for 600 mg) adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed...
www.fosterandthrive.comGuaifenesin USP, 600 mg (for 600mg)
Guaifenesin USP, 1200 mg (for 1200 mg)
Expectorant
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
cough accompanied by too much phlegm (mucus)
ask a health professional before use.
In case of overdose, get medical help or contact aPoison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, ferric oxide red, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A
call 1-833-358-6431Monday to Friday 9:00am to 7:00pm EST
You may also report side effects to this phone number.
Distributed by:
McKesson Corp., via Strategic Sourcing Services LLC.
Memphis, TN 38141
Money Back Guarantee
Product of India
Guaifenesin Extended-Release Tablets600 mg
Carton Label
Guaifenesin Extended-Release Tablets1200 mg
Carton Label
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-1257-1 | EA - Each | 70677-1257 | 0eb577c9-f5fa-4f06-8e4c-948ca2c9e09e | 1 | 2025-05-14 |
| 70677-1257-2 | EA - Each | 70677-1257 | 10d0d3f3-5834-4df3-ad98-eb942b4dab6f | 1 | 2025-05-14 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67296-2351 | 67296-2351-2 |
| 70677-1257 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215932-001 | GUAIFENESIN | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | ||
| A215932-002 | GUAIFENESIN | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A215932-001 | GUAIFENESIN | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A215932-002 | GUAIFENESIN | 1.2GM | TABLET, EXTENDED RELEASE / ORAL | 2022-03-15 | 5d02ea3f76ae… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guaifenesin 600 mg | GUAIFENESIN | Strategic Sourcing Services, LLC | 469c5f00-1b6c-6fc7-a352-65764ff25d45 | 2024-11-09 | Warnings | 70677-1257 |
Adverse event summaries are temporarily unavailable. Other product information remains available.